Morgan Lewis Life Sciences Growth Webinar Series

From CRISPR-Cas9 to iPSCs and mRNA inhibitors, cell and gene therapies represent the cutting edge of innovation. While this exciting and rapidly developing field continues to revolutionize the pharmaceutical and biotechnology industry, it also presents unique legal and regulatory challenges. Please join us for a discussion of some of the key legal and regulatory issues impacting the cell and gene therapy space.

Please join us for the next installment of the Life Sciences Growth Series, focused on university licensing. This webinar gives an overview of university licensing, what it is, the motivation behind it, and university-specific policies and laws.

Recent scientific advancements have revolutionized the way food and agricultural products are being grown, sold, and regulated. Partner Robert Hibbert provides an overview of some of these advancements and what these technologies mean for the food/agricultural industry going forward.

Over the past year, FDA has continued to issue new guidance documents and policy statements on its regulation of software and other digital health technologies. This webinar provides an update on recent FDA actions and expected future developments.
Presentation available upon request.

This session includes a discussion of CFIUS (Committee on Foreign Investment in the United States) national security review issues, export control, sanctions and trade issues, as well as the protection of intellectual property rights, choice and conflicts of law, and dispute resolution.

This webinar guides startup and early-stage companies on the due diligence and preparation needed for a Series A investment.

This webinar gives an overview of university licensing, what it is, the motivations behind it, and university-specific policies and laws.